Recommendations for prevention and control of influenza in children, 2019–2020

Yvonne A. Maldonado, Theoklis E. Zaoutis, Ritu Banerjee, Elizabeth D. Barnett, James D. Campbell, Mary T. Caserta, Jeffrey S. Gerber, Athena P. Kourtis, Ruth Lynfield, Flor M. Munoz, Dawn Nolt, Ann Christine Nyquist, Sean T. O’Leary, William J. Steinbach, Ken Zangwill, Henry H. Bernstein, David W. Kimberlin, H. Cody Meissner, Mark H. Sawyer, Stuart T. WeinbergJohn M. Kelso, John S. Bradley, Tim Uyeki, Amanda C. Cohn, Tammy R. Beckman, Jamie Deseda-Tous, Karen M. Farizo, Marc Fischer, Natasha B. Halasa, Nicole Le Saux, Scot Moore, Neile S. Silverman, Jeffrey R. Starke, James J. Stevermer, Kay M. Tomashek, Jennifer M. Frantz

Research output: Contribution to journalArticlepeer-review

36 Scopus citations


This statement updates the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2019–2020 season. The American Academy of Pediatrics continues to recommend routine influenza immunization of all children without medical contraindications, starting at 6 months of age. Any licensed, recommended, age-appropriate vaccine available can be administered, without preference of one product or formulation over another. Antiviral treatment of influenza with any licensed, recommended, age-appropriate influenza antiviral medication continues to be recommended for children with suspected or confirmed influenza, particularly those who are hospitalized, have severe or progressive disease, or have underlying conditions that increase their risk of complications of influenza.

Original languageEnglish (US)
Article numbere20192478
Issue number4
StatePublished - 2019

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Recommendations for prevention and control of influenza in children, 2019–2020'. Together they form a unique fingerprint.

Cite this